China's NMPA approves initiation of phase I/II trial of AK-117 for medium- to high-risk MDS May 20, 2021 No Comments
Hanmi initiates phase II study of FLX-475 in combination with pembrolizumab in gastric cancer May 20, 2021 No Comments
Enrollment begins in investigator-initiated study of D2C7-IT plus 2141-V11 in recurrent glioma May 19, 2021 No Comments
ImmunityBio receives FDA authorization for phase I study of its m-ceNK platform May 19, 2021 No Comments
Combined administration of BNT-152 and BNT-153 results in synergistic antitumor effects May 17, 2021 No Comments
Preliminary clinical data of highly purified chimeric antigen receptor T-cell therapy targeting CD19 May 14, 2021 No Comments
RSS